The GEne Therapy INnovation Training Network

Project Information

GET-IN

Grant agreement ID: 101119880

DOI

10.3030/101119880

EC signature date 5 July 2023

Start date 1 September 2023

End date 31 August 2027

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost

No data

EU contribution

€ 2 615 796,00

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (5)

Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival

Author(s): Alejandra Gutierrez-Guerrero, Séverine Périan, Aurélien Leray, Chiara Martinello, Maria Jimena Abrey Recalde, Caroline Costa, Cecilia Iglesias Herrero, Mohammed Bouzelha, Dimitri Alvarez-Dorta, Sébastien G. Gouin, Eduard Ayuso, Oumeya Adjali, Hildegard Büning, David Deniaud, Mathieu Mével, Els Verhoeyen
Published in: Molecular Therapy Nucleic Acids, Issue 36, 2025, ISSN 2162-2531
Publisher: Elsevier BV
DOI: 10.1016/J.OMTN.2025.102495

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

Author(s): Adrien Krug, Aymen Saidane, Chiara Martinello, Floriane Fusil, Alexander Michels, Christian J. Buchholz, Jean-Ehrland Ricci, Els Verhoeyen
Published in: Journal of Experimental & Clinical Cancer Research, Issue 43, 2024, ISSN 1756-9966
Publisher: Springer Science and Business Media LLC
DOI: 10.1186/s13046-024-03179-5

Cystic fibrosis at a glance: from disease mechanism to therapy

Author(s): Kasper Gryspeert, Laudonia L. Dipalo, Ana L. Da Silva Cunha, Mattijs Bulcaen, Marjolein M. Ensinck, Marianne S. Carlon
Published in: Trends in Molecular Medicine, Issue 31, 2025, ISSN 1471-4914
Publisher: Elsevier BV
DOI: 10.1016/J.MOLMED.2025.02.001

Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities

Author(s): Tengku Ibrahim Maulana, Nienke R. Wevers, Theodora Kristoforus, Morgan Chandler, Henriette L. Lanz, Jos Joore, Paul Vulto, Remi Villenave, Stefan Kustermann, Peter Loskill, Kristin M. Bircsak
Published in: Annual Review of Pharmacology and Toxicology, Issue 65, 2025, ISSN 0362-1642
Publisher: Annual Reviews
DOI: 10.1146/ANNUREV-PHARMTOX-061724-080621

Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis

Author(s): Laudonia Lidia Dipalo, Jacob Giehm Mikkelsen, Rik Gijsbers, Marianne S. Carlon
Published in: Human Gene Therapy, Issue 36, 2025, ISSN 1043-0342
Publisher: Mary Ann Liebert Inc
DOI: 10.1089/HUM.2024.258

Other (1)

Additional file 1 of In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

Author(s): Krug, Adrien; Saidane, Aymen; Martinello, Chiara; Fusil, Floriane; Michels, Alexander; Buchholz, Christian J.; Ricci, Jean-Ehrland; Verhoeyen, Els
Published in: 2024
DOI: 10.6084/M9.FIGSHARE.27019260